- Home
- ETON vs BCSF Comparison
ETON vs BCSF Comparison
Compare ETON & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | BCSF |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.8M | 799.8M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ETON | BCSF |
|---|---|---|
| Price | $30.72 | $14.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $39.33 | $14.00 |
| AVG Volume (30 Days) | 346.1K | ★ 367.0K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 14.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | N/A |
| Revenue Next Year | $47.23 | N/A |
| P/E Ratio | ★ N/A | $9.29 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $11.82 |
| 52 Week High | $31.12 | $16.00 |
Technical Indicators
Market Signals| Indicator | ETON | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 73.57 | 69.52 |
| Support Level | $15.79 | $13.47 |
| Resistance Level | N/A | $14.53 |
| Average True Range (ATR) | 1.48 | 0.29 |
| MACD | 0.46 | 0.09 |
| Stochastic Oscillator | 82.77 | 86.78 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.